정형외과 약물 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 비율 증가, 정형외과 약물의 연구개발에 대한 투자 증가일 것으로 예측됩니다. 주요 동향으로서는 표적 생물 제제의 진보, 재생 의료 요법의 채용, 개별화된 약제 제제, 저침습 전달법의 혁신, 유전자 치료에 의한 약효 증강, 주사제 제제의 발전 등 약제 개발과 임상 의사 결정 과정에 인공지능 통합 등이 있습니다.
근골격계 장애의 유병률 증가는 정형외과 약물 시장의 확대를 촉진할 것으로 예측됩니다. 시스템의 움직임과 기능에 영향을 미치고 통증과 운동 제한으로 이어지는 상해와 상태가 포함됩니다. 좌식 생활 방식, 불충분한 영양, 유전적 소인 등의 요인에 의한 것입니다. 궁극적으로 가동성과 전반적인 삶의 질을 향상시키고 근골격계 장애 관리에 중요한 역할을 합니다. for Health Improvement and Disparities는 2022년 16세 이상의 개인의 17.6%가 관절염과 지속적인 등과 관절 문제와 같은 장기 근골격계(MSK) 질환을 앓고 있으며 2021년 17.0%에서 증가하고 있다고 보고했습니다. 2022년 7월, 스위스에 본부를 둔 정부간 기관인 세계보건기구는 세계에서 약 17억 1,000만명이 근골격계 장애로 고통받고 있다고 추정했습니다.
정형외과 약물 분야의 주요 기업은 시장 진입 확대, 환자 결과 개선, 다양한 정형외과 질환에서 미충족 의료 의료 요구에 대한 대응 등을 목적으로 자사 약물의 적응 확대를 우선하고 있습니다. Heron Therapeutics Inc.는 발과 발목 수술을 포함한 연부 조직 및 정형외과 수술에서 ZYNRELEF(부피바카인 및 멜록시 캠)의 사용 확대에 대한 FDA 승인을 받았습니다. 수술 후 오피오이드 약물의 필요성을 최소화하거나 제거하여 최대 72시간 동안 통증을 완화하도록 특별히 설계되었습니다. 적응증의 확대에 의해 정형외과 수술이나 연부 조직 수술의 범위가 넓어져, 임상 현장에서의 사용 범위가 확대되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 정형외과 약물 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 정형외과 약물 시장 : 성장률 분석
- 세계의 정형외과 약물 시장 실적 : 규모와 성장, 2019-2024
- 세계의 정형외과 약물 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 정형외과 약물 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 정형외과 약물 시장 : 약제유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비스테로이드성 항염증제(NSAID)
- 오피오이드
- 코르티코스테로이드
- 질환 수식 항류마티스약(DMARD)
- 기타 약물의 유형
- 세계의 정형외과 약물 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 골관절염
- 류마티스 관절
- 골다공증
- 기타 용도
- 세계의 정형외과 약물 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 정형외과 약물 시장 : 비스테로이드성 항염증약(NSAIDs)유형별 서브세그먼테이션, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 이부프로펜
- 나프록센
- 디클로페낙
- 셀레콕시브
- 인도메타신
- 세계의 정형외과 약물 시장 : 오피오이드유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 모르핀
- 옥시코돈
- 히드로코돈
- 펜타닐
- 트라마돌
- 세계의 정형외과 약물 시장 : 코르티코스테로이드유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 프레드니손
- 메틸프레드니솔론
- 덱사메타손
- 하이드로코르티손
- 베타메타손
- 세계의 정형외과 약물 시장 : 질환 수식성 항류마티스약(DMARD)유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 메토트렉세이트
- 히드록시클로로킨
- 레플루노미드
- 술파살라진
- 아자티오프린
- 세계의 정형외과 약물 시장 : 기타 약제 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비스포스포네이트
- 칼시토닌
- 단일클론항체
- 근육 이완제
- 히알루론산 주사
제7장 지역별, 국가별 분석
- 세계의 정형외과 약물 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 정형외과 약물 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 정형외과 약물 시장 : 경쟁 구도
- 정형외과 약물 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Bayer AG
- Sanofi SA
- Bristol-Myers Squibb Company
- AstraZeneca plc
- GSK Plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Biogen Inc.
- UCB SA
- Allergan plc
- Penardo Biotech Pvt. Ltd.
- Horizon Therapeutics plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 정형외과 약물 시장 2029 : 새로운 기회를 제공하는 국가
- 정형외과 약물 시장 2029 : 새로운 기회를 제공하는 부문
- 정형외과 약물 시장 2029 : 성장 전략
제36장 부록
SHW
Prescription orthopedic drugs are medications specifically prescribed to treat musculoskeletal conditions affecting bones, joints, muscles, and ligaments. These drugs help relieve pain, reduce inflammation, and promote healing in orthopedic injuries and disorders such as arthritis, fractures, and tendonitis.
The primary types of prescription orthopedic drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and others. NSAIDs are a class of medications that alleviate pain, inflammation, and fever by inhibiting enzymes responsible for prostaglandin production. These drugs are commonly used to manage conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The prescription orthopedic drugs market research report is one of a series of new reports from The Business Research Company that provides prescription orthopedic drugs market statistics, including the prescription orthopedic drugs industry's global market size, regional shares, competitors with a prescription orthopedic drugs market share, detailed prescription orthopedic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription orthopedic drugs industry. This prescription orthopedic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $48.41 billion in 2024 to $51.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period was driven by the rising prevalence of musculoskeletal disorders, an increasing geriatric population, greater awareness of osteoporosis treatments, expanded healthcare access in developing regions, and a surge in sports-related injuries worldwide.
The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $65.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period is expected to be driven by the rising demand for biologics, an increasing geriatric population, expanded healthcare access in emerging markets, a growing prevalence of chronic musculoskeletal disorders, and increased investments in orthopedic drug research and development. Key trends include advancements in targeted biologics, the adoption of regenerative medicine therapies, personalized drug formulations, innovations in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, developments in injectable formulations, and the integration of artificial intelligence in drug development and clinical decision-making.
The growing prevalence of musculoskeletal disorders is expected to propel the expansion of the prescription orthopedic drugs market. Musculoskeletal disorders (MSDs) encompass injuries and conditions that impact the movement and function of the body's musculoskeletal system, including muscles, tendons, ligaments, nerves, and joints, leading to pain and restricted mobility. The rising occurrence of these disorders can be attributed to factors such as aging, occupational activities involving repetitive motions and awkward postures, sedentary lifestyles, inadequate nutrition, and genetic predispositions. Prescription orthopedic drugs play a crucial role in managing musculoskeletal disorders by alleviating pain, reducing inflammation, and promoting the healing process, ultimately improving mobility and overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department for public health, reported that 17.6% of individuals aged 16 and older in 2022 had a long-term musculoskeletal (MSK) condition, such as arthritis or persistent back or joint problems, an increase from 17.0% in 2021. Additionally, in July 2022, the World Health Organization, a Switzerland-based intergovernmental organization, estimated that approximately 1.71 billion people worldwide suffer from musculoskeletal disorders. As a result, the increasing prevalence of musculoskeletal disorders is fueling the growth of the prescription orthopedic drugs market.
Leading companies in the prescription orthopedic drugs sector are prioritizing the expansion of indications for their drugs to extend market reach, enhance patient outcomes, and address unmet medical needs across various orthopedic conditions. For instance, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, received FDA approval for the extended use of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This extended-release formulation is specifically designed to provide prolonged pain relief for up to 72 hours, minimizing or eliminating the need for opioid medications post-surgery. The expanded indication now encompasses a wider range of orthopedic and soft tissue procedures, broadening its use in clinical settings. The drug's innovative dual-drug combination delivers both local anesthetic and anti-inflammatory effects, offering a comprehensive solution for managing post-operative pain while improving patient outcomes.
In April 2024, ProMed Pharma LLC, a US-based pharmaceutical company, acquired SpineThera Inc. for an undisclosed sum. Through this acquisition, ProMed aims to strengthen its drug delivery capabilities by utilizing SpineThera's expertise in extended-release injectable therapies, particularly in pain management for musculoskeletal and orthopedic conditions. SpineThera Inc. is a US-based company specializing in the development of extended-release injectable therapies for treating musculoskeletal conditions, including back pain and orthopedic disorders.
Major players in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc.
North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in prescription orthopedic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the prescription orthopedic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The prescription orthopedic drugs market consists of sales of products such as bisphosphonates, creams, gels, or patches, calcium and vitamin D supplements, and analgesics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prescription Orthopedic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prescription orthopedic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prescription orthopedic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription orthopedic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Corticosteroids; Disease-Modifying Antirheumatic Drugs (DMARDs); Other Drug Types
- 2) By Application: Osteoarthritis; Rheumatoid Arthritis; Osteoporosis; Other Applications
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Diclofenac; Celecoxib; Indomethacin
- 2) By Opioids: Morphine; Oxycodone; Hydrocodone; Fentanyl; Tramadol
- 3) By Corticosteroids: Prednisone; Methylprednisolone; Dexamethasone; Hydrocortisone; Betamethasone
- 4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate; Hydroxychloroquine; Leflunomide; Sulfasalazine; Azathioprine
- 5) By Other Drug Types: Bisphosphonates; Calcitonin; Monoclonal Antibodies; Muscle Relaxants; Hyaluronic Acid Injections
- Companies Mentioned:Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck KGaA; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Prescription Orthopedic Drugs Market Characteristics
3. Prescription Orthopedic Drugs Market Trends And Strategies
4. Prescription Orthopedic Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Prescription Orthopedic Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Prescription Orthopedic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Prescription Orthopedic Drugs Market Growth Rate Analysis
- 5.4. Global Prescription Orthopedic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Prescription Orthopedic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Prescription Orthopedic Drugs Total Addressable Market (TAM)
6. Prescription Orthopedic Drugs Market Segmentation
- 6.1. Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Opioids
- Corticosteroids
- Disease-Modifying Antirheumatic Drugs (DMARDs)
- Other Drug Types
- 6.2. Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Osteoarthritis
- Rheumatoid Arthritis
- Osteoporosis
- Other Applications
- 6.3. Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- 6.4. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ibuprofen
- Naproxen
- Diclofenac
- Celecoxib
- Indomethacin
- 6.5. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Morphine
- Oxycodone
- Hydrocodone
- Fentanyl
- Tramadol
- 6.6. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prednisone
- Methylprednisolone
- Dexamethasone
- Hydrocortisone
- Betamethasone
- 6.7. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Methotrexate
- Hydroxychloroquine
- Leflunomide
- Sulfasalazine
- Azathioprine
- 6.8. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bisphosphonates
- Calcitonin
- Monoclonal Antibodies
- Muscle Relaxants
- Hyaluronic Acid Injections
7. Prescription Orthopedic Drugs Market Regional And Country Analysis
- 7.1. Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Prescription Orthopedic Drugs Market
- 8.1. Asia-Pacific Prescription Orthopedic Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prescription Orthopedic Drugs Market
- 9.1. China Prescription Orthopedic Drugs Market Overview
- 9.2. China Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prescription Orthopedic Drugs Market
- 10.1. India Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prescription Orthopedic Drugs Market
- 11.1. Japan Prescription Orthopedic Drugs Market Overview
- 11.2. Japan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prescription Orthopedic Drugs Market
- 12.1. Australia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prescription Orthopedic Drugs Market
- 13.1. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prescription Orthopedic Drugs Market
- 14.1. South Korea Prescription Orthopedic Drugs Market Overview
- 14.2. South Korea Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prescription Orthopedic Drugs Market
- 15.1. Western Europe Prescription Orthopedic Drugs Market Overview
- 15.2. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prescription Orthopedic Drugs Market
- 16.1. UK Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Prescription Orthopedic Drugs Market
- 17.1. Germany Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prescription Orthopedic Drugs Market
- 18.1. France Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Prescription Orthopedic Drugs Market
- 19.1. Italy Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Prescription Orthopedic Drugs Market
- 20.1. Spain Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prescription Orthopedic Drugs Market
- 21.1. Eastern Europe Prescription Orthopedic Drugs Market Overview
- 21.2. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prescription Orthopedic Drugs Market
- 22.1. Russia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prescription Orthopedic Drugs Market
- 23.1. North America Prescription Orthopedic Drugs Market Overview
- 23.2. North America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prescription Orthopedic Drugs Market
- 24.1. USA Prescription Orthopedic Drugs Market Overview
- 24.2. USA Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Prescription Orthopedic Drugs Market
- 25.1. Canada Prescription Orthopedic Drugs Market Overview
- 25.2. Canada Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prescription Orthopedic Drugs Market
- 26.1. South America Prescription Orthopedic Drugs Market Overview
- 26.2. South America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prescription Orthopedic Drugs Market
- 27.1. Brazil Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prescription Orthopedic Drugs Market
- 28.1. Middle East Prescription Orthopedic Drugs Market Overview
- 28.2. Middle East Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prescription Orthopedic Drugs Market
- 29.1. Africa Prescription Orthopedic Drugs Market Overview
- 29.2. Africa Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prescription Orthopedic Drugs Market Competitive Landscape And Company Profiles
- 30.1. Prescription Orthopedic Drugs Market Competitive Landscape
- 30.2. Prescription Orthopedic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Prescription Orthopedic Drugs Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Sanofi S.A.
- 31.3. Bristol-Myers Squibb Company
- 31.4. AstraZeneca plc
- 31.5. GSK Plc
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Eli Lilly and Company
- 31.8. Amgen Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Mylan N.V.
- 31.11. Biogen Inc.
- 31.12. UCB S.A.
- 31.13. Allergan plc
- 31.14. Penardo Biotech Pvt. Ltd.
- 31.15. Horizon Therapeutics plc
32. Global Prescription Orthopedic Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Prescription Orthopedic Drugs Market
34. Recent Developments In The Prescription Orthopedic Drugs Market
35. Prescription Orthopedic Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Prescription Orthopedic Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Prescription Orthopedic Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Prescription Orthopedic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
